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Abstract 30 
Atrial fibrillation (AF) affects ~3% of the general population and is twice as common with 31 
hypertension. Validation protocols for automated sphygmomanometers exclude people with AF, 32 
raising concerns over accuracy of hypertension diagnosis or management, using out-of-office blood 33 
pressure (BP) monitoring, in the presence of AF. Some devices include algorithms to detect AF; a 34 
feature open to misinterpretation as offering accurate BP measurement with AF. We undertook this 35 
review to explore accuracy of automated devices, with or without AF detection, for measuring BP. 36 
We searched Medline and Embase to October 2018 for studies comparing automated BP 37 
measurement devices to a standard mercury sphygmomanometer contemporaneously. Data were 38 
extracted by two reviewers. Mean BP differences between devices and mercury were calculated, 39 
where not reported and compared; meta-analyses were undertaken where possible. 40 
We included 13 studies reporting 14 devices. Mean systolic and diastolic BP differences from 41 
mercury ranged from -3.1 to +6.1/-4.6 to +9.0 mmHg. Considerable heterogeneity existed between 42 
devices (I2 80% to 94%). Devices with AF detection algorithms appeared no more accurate for BP 43 
measurement with AF than other devices.  44 
A previous review concluded that oscillometric devices are accurate for systolic but not diastolic BP 45 
measurement in AF. The present findings do not support that conclusion. Due to heterogeneity 46 
between devices, they should be evaluated on individual performance. We found no evidence that 47 
devices with AF detection measure BP more accurately in AF than other devices. More home or 48 
ambulatory automated BP monitors require validation in populations with AF. 49 
 50 
246 words 51 
 52 
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Summary Table 54 
 55 
What is known about the topic 56 
• Hypertension and atrial fibrillation commonly co-exist, so accurate blood pressure 57 
measurement is important to facilitate diagnosis and treatment. 58 
• Guidelines recommend manual measurement of blood pressure with atrial fibrillation, but 59 
also place emphasis on out of office measurement for diagnosis and management of 60 
hypertension. 61 
• Previous evidence suggests that automated blood pressure monitors are accurate for 62 
systolic but not diastolic blood pressure measurement in the presence of atrial fibrillation. 63 
What this study adds 64 
• Whilst individual monitors have been shown to be accurate with atrial fibrillation, there is 65 
considerable heterogeneity between devices, particularly for diastolic blood pressure 66 
measurement, when compared to a mercury standard. Therefore accuracy for other devices 67 
in atrial fibrillation cannot be assumed. 68 
• There are relatively few studies of accuracy in atrial fibrillation, in comparison to the number 69 
of different devices in current clinical use. 70 
• Most published studies are of limited size, and all were conducted on populations who may 71 
not represent the wider population with atrial fibrillation. 72 
 73 
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Introduction 75 
Raised blood pressure (BP, hypertension) is the main risk factor globally for premature morbidity and 76 
mortality.1 Control of hypertension is fundamental for the prevention of cardiovascular disease, yet 77 
international data show that the prevalence of hypertensive heart disease is not declining.1, 2 Atrial 78 
fibrillation (AF) affects 2-3% of adults in Europe and the USA, and over 10% of those aged 80 years or 79 
older;3, 4 prevalence is expected to double in the next 50 years as the population ages.5 Hypertension 80 
is a risk factor for, and approximately doubles the risk of, AF due to development of left ventricular 81 
hypertrophy and electrical remodelling where BP control is suboptimal.6, 7 Hypertension is found in 82 
half of those with AF, thus obtaining accurate BP readings is an important component of their 83 
diagnosis and managment.8 Current guidelines advise that BP should be measured manually when 84 
the pulse is irregular.9, 10 International protocols for the validation of BP monitors all exclude subjects 85 
with an irregular pulse, identifying those with AF as a special poulation.11, 12 In the absence of agreed 86 
guidelines for BP measurement in AF it is not, therefore, possible to claim validation for accuracy of 87 
BP readings for any monitor in the presence of AF.12, 13 However, studies have undertaken 88 
comparisons of various automated BP measurement devices with mercury sphygmomanometers, 89 
which themselves are disappearing from clinical use on environmental grounds. In fact, a previous 90 
review suggested that automated monitors might be accurate in measuring systolic but not diastolic 91 
BP where AF is present.14 Automated devices are easy to operate and eliminate observer bias, and 92 
are now preferred in some hypertension guidelines.15 There are suggestions that office BP may be 93 
reasonably measured oscillometrically in some AF patients. This is a matter of debate,16, 17 but out of 94 
office BP measurement, by definition, relies on the use of automated devices.13 More recently, 95 
automated BP devices are incorporating algorithms for the detection of AF; 18-23 one (Microlife 96 
WatchBP Home A device) being the subject of a positive National Institute for Health and Care 97 
Excellence (NICE) Technology Appraisal. 19, 24 We therefore carried out a systematic review of the 98 
literature to a) update the evidence base and to inform a position statement on recommendations 99 
on BP measurement in the presence of AF (INSERT REFERENCE TO POSITION STATEMENT), and b) to 100 
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understand the accuracy of newer devices with AF detection in measuring BP, in comparison to 101 
other devices. 102 
 103 
Methods 104 
We searched Medline and Embase from inception to 26th October 2018 using a broad search 105 
strategy (Box 1). Searches were augmented by checking reference lists in review and commentary 106 
articles retrieved. We also reviewed relevant journal collections, conference abstracts, relevant 107 
guidelines and personal archives for additional citations. We included studies that compared 108 
brachial BP measurements using oscillometric or other automated devices with auscultatory 109 
mercury sphygmomanometer measurement (as our non-invasive gold standard). Comparison could 110 
be by either a simultaneous or contemporaneous sequential method. We sought studies of home, 111 
office or ambulatory BP monitoring devices with, or without, automated AF detection functions. It is 112 
important to note that we did not undertake assessment of the accuracy of AF detection of such 113 
devices.  114 
We excluded studies that split comparisons over different assessment sessions, retrospective 115 
analyses, case reports, device studies not comparing BP measurements as primary outcome and 116 
those using intra-arterial BP measurement as gold standard. We assessed conference abstracts as 117 
eligible where sufficient data and detail could be extracted. Searches were confined to English 118 
language papers. Selections were made by one reviewer and checked by a second, with discussion 119 
and resolution of disagreements. 120 
Data on study details and populations were extracted by two reviewers. We included mean and 121 
variance of BP readings for automated devices and mercury comparisons and, where reported, the 122 
proportions of systolic and diastolic BP readings reaching agreement within 5, 10 or 15 mmHg, for 123 
comparison with the relevant standards of the European Society for Hypertension (ESH) 2010 124 
International Protocol for validation of BP measuring devices.11 Mean differences were expressed as 125 
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device minus mercury values. Where not reported, differences between devices and mercury were 126 
calculated from the reported BP values using a matched pairs approach, with adjustment for intra-127 
class correlation coefficients for systolic and diastolic BP reported in a previous review.14, 25 Meta-128 
analyses of pooled data were undertaken using random effects models in Stata v14.0. Two reviewers 129 
undertook independent quality assessment of included studies with the QUADAS-2 tool.26 130 
 131 
 132 
Medline 
1. Exp blood pressure determination 
2. Exp atrial fibrillation 
3. 1 AND 2 
 
Embase: 
1. Blood pressure measurement
2. Atrial fibrillation 
3. 1 AND 2 
Box 1. Search strategy 133 
 134 
 135 
Results 136 
Searches up to 26th October 2018 retrieved a total of 746 unique citations. Fifty nine full texts were 137 
assessed for eligibility and 13 studies covering 14 devices met inclusion criteria (Figure 1). There 138 
were no disagreements on data extraction between reviewers. There were eight studies of 139 
automated BP monitors designed for home and/or office use,27-34 and six studies of four ambulatory 140 
BP devices;27, 35-39 one of these only reported mean 24 hour ambulatory BP, as opposed to 141 
contemporaneous measurement with mercury comparison, so was not included in meta-analyses.35 142 
Three studies used a simultaneous method to compare BP measurements,30, 34, 39 the remainder used 143 
varied sequential protocols. Studies were all undertaken in hospital settings, recruiting either 144 
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inpatients, outpatients or both, and the mean ages of participants ranged from 68 to 83 years (Table 145 
1). Six studies reported achievement of some, or all, of the standards for the 2010 International 146 
Protocol, although none adopted the precise protocol itself.27, 29, 30, 32, 34, 39 Four of the devices studied 147 
included AF or arrhythmia detection features.31, 32, 34-36 148 
Mean BP differences between mercury and automated devices were reported, or calculated from 149 
data, for nine studies: For six home or office devices, the pooled systolic difference from mercury 150 
standard was 1.0 mmHg (-1.1 to 3.1; I2 = 81%; Figure 2); heterogeneity was accounted for by 151 
exclusion of one outlying study on the Microlife BP A6 (Microlife, Heerbrugg, Switzerland),31 pooled 152 
difference from mercury on exclusion was -0.2 mmHg (-1.1 to 0.8; I2 = 24%). Pooled diastolic 153 
difference was 1.5 mmHg (-1.4 to 4.5; I2 = 94%; Figure 3), heterogeneity could not be accounted for 154 
by any one study. 155 
For two ambulatory devices (three studies), pooled systolic difference from mercury was 0.5 mmHg 156 
(-0.9 to 1.9; I2 = 0%; Figure 2) and pooled diastolic difference was 2.0 mmHg (2.8 to 6.8; I2 = 92%; 157 
Figure 3). Diastolic heterogeneity was accounted for by between device differences: A&D-TM-2430 158 
(A&D Company, Tokyo, Japan) difference form mercury -2.4 mmHg (-4.1 to -0.7; I2 = 0%) and 159 
Spacelabs 90207 (Spacelabs Healthcare, WA, USA) 6.4 mmHg (2.1 to 10.6; I2 = 68%). 160 
QUADAS-2 quality assessments identified some concern over risk of bias, usually due to unclear 161 
reporting of recruitment strategies, for all but two studies.35, 39 Inspection of funnel plots quantified 162 
with Egger’s tests did not suggest evidence of small study publication bias (systolic and diastolic BP; 163 
P = 0.15).40 Levels of agreement varied between and within device manufacturers. 164 
Six studies of nine devices reported proportions of readings differing from mercury standard for one 165 
or more of the thresholds set by the 2010 International Protocol (Table 2).11 Reporting of all 166 
thresholds was only complete in four studies.30, 39, 41, 42 In single studies, only one home device, the 167 
Tensoval duo control (Hartmann-Rico AG, Heidenheim, Germany), and one ambulatory device, the 168 
Spacelabs 90207, met all standards for BP accuracy; one other study of Spacelabs 90207 only 169 
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reported against the 5 mmHg thresholds, which were not met.27 The Microlife Watch BPA100Plus 170 
(Microlife, Heerbrugg, Switzerland) met the systolic but not the diastolic BP standards. 171 
Four devices studied feature AF or arrhythmia detection indicators: the Tensoval duo control, 172 
Microlife BP A6, Microlife Watch BPA100Plus and the A&D-TM-2430.31, 32, 34-36 Of these, all except the 173 
Microlife BP A6 agreed well for systolic BPs. Only the Tensoval device was also accurate for diastolic 174 
BP, although the Microlife BPA6 also showed reasonable diastolic agreement. 175 
 176 
Discussion 177 
This systematic review and meta-analysis examined the available evidence for accuracy of 178 
automated BP measurements compared to a mercury standard. We only found data assessing 14 179 
devices, a number of which are no longer in production. This represents only a small proportion of 180 
the monitors currently available on the market. We found considerable heterogeneity of BP 181 
differences according to individual device and type of device, which limited our ability to draw 182 
general conclusions.  183 
For systolic BP measurement, ambulatory measurements with either the A&D-TM-2430 device or 184 
the Spacelabs 90207 appeared comparable to mercury readings, whilst, for clinical or home settings, 185 
reports showed good agreement for the Philips Sure Signs VSi (Philips Medical Systems, Andover, 186 
Massachusetts, USA), Welch Allyn Vital Sign 300 (Welch Allyn, Beaverton, Oregon, USA), Microlife 187 
Watch BPA100Plus and the Tensoval duo control. The latter was the only monitor that met the 188 
International Protocol limits of agreement for both systolic and diastolic BP.  189 
The Microlife Watch BPA100Plus met the systolic International Protocol standards but also 190 
underestimated systolic BP by 3mmHg. Two other devices, the Omron HEM-750CP (Omron 191 
Healthcare Co. Ltd, Kyoto, Japan) and the Microlife BPA6, overestimated systolic BP by 5 to 6mmHg. 192 
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For diastolic BP measurements, the A&D-TM-2430 ambulatory BP monitor underestimated BP by 2 193 
mmHg whilst the Spacelabs 90207 overestimated it by 6 mmHg.  Among home and office devices 194 
accurate for systolic readings, only the Tensoval device performed accurately for diastolic BP as well.  195 
Our review included four monitors with AF detection technology. Accuracy was not consistently 196 
better for these devices with considerable inter-device variation between the two Microlife devices, 197 
and no evidence of better overall performance compared to devices without AF detection features 198 
was noted. 199 
 200 
Strengths and weaknesses 201 
Pooled analysis of findings was limited by a lack of data, and relatively small sample sizes in most 202 
studies. The mean age of participants was high (~70 years), with little evidence to support any 203 
judgement on accuracy of monitors in participants of a younger age. Since AF is an age related 204 
condition this may not be important.4 We undertook comprehensive searches and sought 205 
unpublished data from colleagues actively researching in the field, however, there may be 206 
manufacturer’s data that we were not able to access. The key limitation in this review is the 207 
restricted number of devices that appear to have any published assessment of their BP measuring 208 
performance in AF. Although we present pooled mean differences from our analyses, the large 209 
variation between device types and within the home and office monitor group, precludes any 210 
assumption that the apparently small pooled mean differences can be generalised to other 211 
monitors. We retrieved, but did not include, a small number of studies reporting device comparison 212 
with intra-arterial BPs, since our interest was in the clinical interpretation of reported BP readings.43-213 
46 Quality assessment using the QADAS-2 tool did not effectively discriminate between studies, 214 
mainly due to unclear reporting of recruitment methods, so no subgroup analyses by study quality 215 
were feasible. 216 
 217 
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Relevance to existing literature 218 
This review updates the 2012 review of Stergiou et al.14 They reviewed eight studies of 11 devices, 219 
and observed that overall study methodology was variable and sample sizes were usually lower than 220 
those dictated for validation studies.11, 47 Their pooled data from six studies showed systolic BP to be 221 
overestimated, on average, by 0.5mmHg (-1.0 to 1.9; I2 =39%) and diastolic BP by 2.5mmHg (-0.6 to 222 
5.7; I2 =93%). Preliminary findings from their current update confirm a similar systolic difference and 223 
unchanged correlation coefficient (0.5mmHg (-1.0 to 1.9); correlation coefficient 0.87), but a smaller 224 
pooled diastolic over-estimation of 1.5mmHg (-0.6 to 3.6); these overall updated pooled figures 225 
remain subject to significant heterogeneity between studies (I2 =77% for systolic and 94% for 226 
diastolic) emphasising the difficulty in generalising across different devices.48 One other recent large 227 
observational study pooling findings across N specialist centres reported correlation coefficients 228 
consistent with previous reviews, and an overall over-estimation of BP of 1.1/0.6mmHg. There was, 229 
however, no standardisation of choice of machine and no analysis by type of device, although this 230 
does represent real clinic observational data.49 For this review, we identified five additional studies 231 
published since the 2012 review,14 covering three new devices.31, 35-37, 39 The Tensoval device study 232 
was the highest weighted single study in the previous review (44%), but inclusion of only full study, 233 
rather than subgroup data, masks a rate dependency for accuracy.41 Nevertheless, it still performed 234 
well against other newer home BP monitors. Overall, we found substantial heterogeneity of accuracy 235 
between devices according to setting and device. Whilst we identified evidence for accuracy of two 236 
ambulatory devices for systolic BP readings, there was greater variation between home or office 237 
monitors. Diastolic BP accuracy varied to a much greater degree in all settings. 238 
Although no study followed the International Protocol for validation of BP devices, a number 239 
reported against its standards.11 Nine studies noted some absolute differences between automated 240 
and auscultatory BP measurements, permitting a partial assessment against this criterion of the 241 
International Protocol.11 Several devices met one standard for systolic BP differences but only the 242 
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Spacelabs 90207 and the Tensoval Duo Control met these International Protocol criteria in full. The 243 
Microlife Watch BPA100Plus met the standards for systolic BP but not diastolic readings. 244 
In AF, beat to beat variations in stroke volume and ventricular filling lead to marked intra-person and 245 
inter-observer variation in measured, particularly diastolic, BP.50 Consequently, automated 246 
oscillometric BP measurement is regarded as inaccurate in the presence of AF. Neither the 2014 247 
NICE guidelines, nor the 2012 European Society for Cardiology guidelines, on management of AF 248 
discuss BP measurement.51, 52 Therefore, current NICE guidance remains that of the 2011 249 
hypertension guideline that BP should be measured manually in the presence of pulse irregularity, 250 
following pulse palpation,9 and this is consistent with European guidelines (ESH 2013).10 It should, 251 
however, be noted that intra and inter observer variability using mercury measurement of BP are 252 
also greater in AF compared with sinus rhythm.53, 54 The systolic and diastolic BP differences may be 253 
a consistent feature of the oscillometric method, which detects systolic and mean BP directly but 254 
derives diastolic BP from an algorithm, leaving it more susceptible to error with pulse irregularity.16 255 
Revised algorithms may be able to improve precision in AF,55 and accuracy can be improved by 256 
repetition of BP measurements.56 We endorse advice to measure BP manually, exercising caution 257 
with oscillometric devices, and recommend at least three BP measurements be undertaken with the 258 
mean systolic BP value adopted, for maximal accuracy. 259 
 260 
Clinical implications 261 
Stergiou et al. concluded that monitors already validated in sinus rhythm against international 262 
protocols are accurate in measuring systolic but not diastolic BP in the presence of sustained AF.14 263 
The heterogeneity between devices in this review, in some cases including different models from the 264 
same manufacturer derived from the same base model, suggests that no assumptions can be made 265 
about the accuracy of other monitors in the presence of AF. We also found that inclusion of AF 266 
detection functions does not indicate a greater likelihood of accuracy in BP measurement and care 267 
should be taken not to assume this in practice. On the available evidence, the Tensoval device 268 
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appears to be a good choice for home BP monitoring in the presence of arrhythmia. This device is, 269 
however, unusual in possessing both oscillometric and auscultatory modes of action. It is able to 270 
detect arrhythmia and selects auscultatory mode in this setting, only using oscillometric mode if 271 
unable to detect Korotkoff sounds. This technology may account for its superior performance 272 
compared to other devices in this review. Importantly, we found no studies of accuracy based 273 
outside of hospital settings where most BP measurement arises, and the available evidence is based 274 
on a range of older populations. 275 
There does, however, seem to be evidence to support accuracy in interpreting systolic ambulatory 276 
BP measurements. Guideline recommendations of adoption of ambulatory BP monitoring for 277 
diagnosis in sinus rhythm are based on robust evidence, associating measurements with outcomes.57 278 
The same cannot yet be said of ambulatory BP measurement in AF however,58 yet given this caveat, 279 
guidelines do not exclude AF patients from ambulatory monitoring.59 The ambulatory devices 280 
covered by this review appear accurate for systolic BP and should be preferred, compared to 281 
unevaluated ambulatory devices. 282 
Given the lack of available evidence for accuracy of most commonly used BP monitors in the 283 
presence of AF, the British and Irish Hypertension Society (BIHS) stresses the importance of a patient 284 
bringing their home BP monitor to appointments, and recommends occasional validation of home 285 
monitors against clinical devices at individual clinic appointments (https://bihsoc.org/wp-286 
content/uploads/2017/11/BP-Measurement-Poster-Automated-2017.pdf). The BIHS also maintains 287 
the only publicly available independent peer reviewed list of BP monitors (https://bihsoc.org/bp-288 
monitors/). 289 
 290 
Further research 291 
The guideline development group for the 2011 NICE guidelines on hypertension remarked on 292 
concerns about the accuracy of automated devices for measuring BP in people with AF and 293 
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considered this an important area for technology development to see if such problems can be 294 
resolved.9 The findings of this review emphasise that caution. There is currently a lack of evidence 295 
regarding the accuracy of most commonly used BP monitors in the presence of AF, and validity of a 296 
device in sinus rhythm cannot be assumed to imply similar accuracy with arrhythmia. Proposals for a 297 
new universal standard for validation of BP monitors recognise this problem, and suggest that 298 
subgroup validation studies in AF should follow successful validation of devices.60 299 
Further work is required to determine which automated BP monitors are suitable for people with 300 
hypertension and AF, to explore whether existing algorithms should be modified or replaced to 301 
improve accuracy of BP measurement in AF compared to mercury standard, and to confirm the 302 
validity of ambulatory BP measurements in predicting cardiovascular outcomes in the presence of 303 
AF.  304 
 305 
Conclusions 306 
The limited data available support the accuracy of some monitors for ambulatory, home or clinical 307 
use to measure and monitor BP in the presence of AF. For most widely used devices, no evidence 308 
has been found. Devices intended for use with AF should be chosen according to existing evidence of 309 
accuracy and have this confirmed by comparison against validated clinical devices for individuals 310 
being assessed. Further validation studies are needed, particularly for devices equipped to detect AF, 311 
before any general conclusions can be drawn regarding accuracy of BP measurement in the presence 312 
of AF. 313 
  314 
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Study ID Subjects Mean age 
(years)
Setting Device description Device 
type
AF or arrhytmia 
detection
BP measurement method QUADAS-2 summary 
judgement - At risk of bias?
Anastas 2008 Male and female patients with AF aged 18 
years or more, arm circumference 27 to 34 
cm, and able to co-operate with protocol
79 Medical telemetry unit of a community 
hospital, Pacific Northwest
Welch Allyn Vital Sign 300 
(Welch-Allyn, Beaverton, 
Oregon) with standard BP 
cuff (5082-206-2, Welch-
Allyn, Tycos Instruments Inc, 
Skanetateles Falls, New 
York)
Office No Single sequential same arm BP measurements were undertaken in randomised 
order using a calibrated mercury sphygmomanometer and a Welch Allyn Vital 
Sign 300 monitor 
Yes
Farsky 2011 Male and female patients aged 18 years or 
more with permanent AF and peripheral 
frequency of up to 100 b
.
min
-1
, 
independent of the disease aetiology
68 Two clinics (Faculty Hospital of Purkyneˇ 
University in Brno and Regional Hospital 
in Novy´ Jicˇı´n) in Czech Republic and 
three clinics (Faculty Hospital of Nursing 
in Pres˘ov and Nitra and Dom srdca, 
Martin) in Slovakia
Tensoval duo control (TDC; 
Hartmann-Rico AG, 
Heidenheim, Germany)
Home Yes Simultaneous arm BP measurements were undertaken using both a calibrated 
mercury sphygmomanometer and a TDC digital device (which offers auscultatory 
and oscillometric BP monitoring methods) 
Yes
Giantin 2013 Male and female inpatients, aged 65 years 
or more, with permanent, stable AF (heart 
rate;  60–100 b
.
min
-1
)
83 Geriatric hospital unit, Padua University 
Hospital
A&D-TM-2430 (Kitamoto Shi, 
Saitama, Japan)
ABPM Yes Using the dominant arm, three BP measurements using the ABPM device were 
calibrated against a standard Hawksley random zero mercury 
sphygmomanometer to confirm that the values did not differ by > 5 mmHg. The 
ABPM device recorded BP at 15 min intervals during the day (0701–2200 hours) 
and at 20 min intervals during the evening and night (2201–0700 hours)
No
Jani 2006 Medically stable male and female patients 
with rate controlled AF (heart rate; 75 
b
.
min
-1
)
70 Cardiology clinic Omron HEM-750CP (Omron 
Healthcare Co. Ltd, Kyoto, 
Japan)
Home No Four supine BP readings were undertaken in the right arm at 2 min intervals, after 
a rest period of 15 min
Yes
Lamb 2010 (Omron) Male and female hospital outpatients or 
inpatients aged 18 years or more with AF 
and stable heart rate and BP for 24 hours
74 Royal University Hospital, Canada Omron HEM 711 AC (Omron 
Healthcare Co. Ltd, Kyoto, 
Japan)
Home No Supine BP readings were recorded in each arm simultaneously using one test 
monitor and the mercury sphygmomanometer. The second test monitor then 
replaced the first and readings were repeated. The mean of two mercury readings 
for each arm was compared with each single device reading for each arm
Yes
Lamb 2010 (Welch-
Allyn)
Male and female hospital outpatients or 
inpatients aged 18 years or more with AF 
and stable heart rate and BP for 24 hours
74 Royal University Hospital, Canada Welch-Allyn 52000 series 
NIBP/oximeter (Welch-Allyn, 
Beaverton, Oregon, USA)
Office No Same as Lamb 2010 (Omron) Yes
Lip 1996 Male and female normotensive and 
hyertensive outpatients with chronic AF
72 Medical outpatient clinic, City Hospital, 
Birmingham, England
Spacelabs 90207 (Spacelabs 
Healthcare, WA, USA) 
ABPM No The ABPM device was calibrated using the mean of two readings from a Hawksley 
random zero mercury sphygmomanometer, taken before and after the first ABPM 
measurement. The ABPM recorded BP every 30 min over a 24 hour period (day: 
0700-2300, night: 2300-0700 hours) and data were condensed into 1 hour 
averages
Yes
Maselli 2015 Male and female patients with persistent 
AF attending a cardiology deparment for 
cardioversion who remained stable with 
or wihout drugs to control hear rate (60-
100 b
.
min
-1
)
68 Department of Cardiology (Centro 
Gallucci – Padua), Padua University 
Hospital
A&D TM-2430 (A&D 
Company, Tokyo, Japan)
ABPM Yes Using the higher reading arm, and after 5 min of supine rest, three 
sphymomanometric (using a mercury Erkameter 300 device) and three 
oscillometric (using the ABPM device) BP measurements were obtained
Yes
Miszkowska-Nagórna 
2017
Male and female patients with stable AF 
attending a clinic for cardioversion
63 Department of Hypertension and 
Diabetology, and the Department of 
Cardiology and Cardiac Electrotherapy of 
the Teaching Hospital of Medical 
University of Gdańsk, Poland
Spacelabs 90207 (Spacelabs 
Healthcare, WA, USA) 
ABPM No After several min of rest, BP was obtained simultaneously using a mercury 
sphygmomanometer and an ABPM oscillometric device (triggered every two 
min). Measurements were repeated 10 times and the average of successfully 
obtained pairs was used for analysis
No
Olson 2002 Male and female AF patients attending a 
clinic for cardioversion
71 Department of Heart Disease, 
Haukeland Hospital, Bergen, Norway
Accutraccer II (Suntech 
Medical Instruments, 
Raleigh, North Carolina, USA, 
or Diasys Integra, Novacor, 
Ruell, France)
ABPM No BP was measured by the standard auscultatory technique by using an aneroid 
sphygmomanometer. Three measurements were performed during seated rest, 
with 1 min intervals. The mean of the last two measurements was noted as the 
patient’s office BP. Thereafter a 24 hour ABPM monitor was fitted
Yes
Selmyte-Besuspare 
2017
Male and female patients with AF and 
arterial hypertension, aged 18 years or 
more
68 Department of Cardiology, Vilnius 
University Hospital, Santariskiu Klinikos, 
Lithuanua
Microlife BP A6 PC with AF 
detection system (Microlife, 
Heerbrugg, Switzerland)
Home Yes After 5 min of rest, four auscultatory BP measurements were performed on the 
non–dominant arm and used as the reference tecnique. Four oscillometric BP 
measurements were then obtained, using the Microlife device, according to the 
manufacturer’s instructions, using the same arm
Yes
Stergiou 2011 Subjects with AF 74 Hypertension Centre, Third University 
Department of Medicine, Sotiria 
Hospital, Athens-Greece
Microlife Watch BPA100Plus 
(Microlife, Heerbrugg, 
Switzerland)
Home Yes Two sets of three BP measurements were obtained using the test device or a 
mercury sphygmomanometer and each set of measurements were averaged to 
give a single systolic and diastolic value
Yes
Stewart 1995 (Takeda 
UA-751)
Male and female inpatients and 
outpatients, with normotension and 
hypertension and confirmed AF
72 Medical wards and outpatient 
department, Western General Hospital, 
Edinburgh, Scotland 
Takeda UA-751 (A&D 
Company, Tokyo, Japan)
Office No BP was measured twice with each device and  a Hawksley random-zero 
sphygmomanometer during seated rest. Hawksley BP readings were taken 
immediately before and after each device test using a sequential arm technique. 
Each patient also had three sequential measurements with the Hawksley 
sphygmomanometer
Yes
Stewart 1995 (Copal 
UA-251)
Male and female inpatients and 
outpatients, with normotension and 
hypertension and confirmed AF
72 Medical wards and outpatient 
department, Western General Hospital, 
Edinburgh, Scotland 
Copal UA-251  (A&D 
Company, Tokyo, Japan)
Office No Same as Stewart 1995 (Takeda UA-751) Yes
Stewart 1995 
(Accutracker 1)
Male and female inpatients and 
outpatients, with normotension and 
hypertension and confirmed AF
72 Medical wards and outpatient 
department, Western General Hospital, 
Edinburgh, Scotland 
Accutracker 1 (Suntech 
Medical Instruments, 
Raleigh, North Carolina, USA)
ABPM No Same as Stewart 1995 (Takeda UA-751) Yes
Stewart 1995 
(Spacelabs 90207)
Male and female inpatients and 
outpatients, with normotension and 
hypertension and confirmed AF
72 Medical wards and outpatient 
department, Western General Hospital, 
Edinburgh, Scotland 
Spacelabs 90207 (Spacelabs 
Healthcare, WA, USA) 
ABPM No Same as Stewart 1995 (Takeda UA-751) Yes
Vazquez-Rodriguez 
2010
Inpatients with AF, aged 24-96 years 74 Short-Stay Medical Unit of the Complexo 
Hospitalario Universitario A Coruña, 
Spain
Philips Sure Signs VSi (Philips 
Medical Systems, Andover, 
MA)
Office No Using the higher reading arm, four automatic and four manual measurements 
were made alternately, with 5 min intervals of rest in between each 
measurement
Yes
Device (study)
Device 
type
≤5mmHg ≤10mmHg ≤15mmHg ≤5mmHg ≤10mmHg
International 
protocol 
standards
All of: 65 81 93 65 81
Two of: 73 87 96 73 87
ABPM devices
Accutracker 1 
(Stewart 1995)
50 36
Spacelabs 
90207 
(Miszkowska-
Nagórna 
2017)**
60 91 96 72 96
Spacelabs 
90207 (Stewart 
1995)
50 29
Home and 
office devices
Copal UA-251 
(Stewart 1995)
68 75
Microlife 
Watch 
BPA100Plus 
(Stergiou 
2011)*
69 85 93 47 76
Omron HEM 
711 AC (Lamb 
2010)
49 72 84 47 77
Takeda UA-751 
(Stewart 1995)
65 54
Systolic agreement Diastolic agree
Tensoval duo 
control (Farsky 
322011)**
80 93.6 97.7 81.6 93.7
Welch Allyn 
Vital Sign 300 
(Anastas 2008)
51 85 85
Welch-Allyn 
52000 (Lamb 
2010)
46 72 81 57 86
ABPM: ambulatory blood pressure monitoring
*meets International Protocol standards for systolic blood pressure accuracy
** meets International Protocol standards for systolic and diastolic blood pressure accuracy
≤15mmHg
93
96
98
88
92
ement
97.3
92
96



